Redmile Group, LLC - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 41 filers reported holding ATYR PHARMA INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Redmile Group, LLC ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q2 2018$1,715,000
-65.7%
1,884,9920.0%0.06%
-69.9%
Q1 2018$4,995,000
-24.4%
1,884,992
-0.1%
0.19%
-32.8%
Q4 2017$6,604,000
-30.7%
1,886,7920.0%0.29%
-38.9%
Q3 2017$9,528,0001,886,7920.47%
Other shareholders
ATYR PHARMA INC shareholders Q4 2017
NameSharesValueWeighting ↓
Polaris Venture Management Co. V, L.L.C. 1,827,992$33,854,00015.10%
EcoR1 Capital, LLC 836,860$15,499,0005.17%
Rock Springs Capital Management LP 408,496$7,565,0000.55%
BVF INC/IL 134,725$2,495,0000.44%
Baker Brothers Advisors 2,335,125$43,247,0000.38%
SPHERA FUNDS MANAGEMENT LTD. 209,027$3,696,0000.36%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 461,530$8,548,0000.28%
MARINER INVESTMENT GROUP LLC 50,665$938,0000.24%
TIVERTON ASSET MANAGEMENT LLC 450,000$8,334,0000.17%
RIVERHEAD CAPITAL MANAGEMENT LLC 415,377$7,693,0000.12%
View complete list of ATYR PHARMA INC shareholders